Korea to add Canada, Australia to drug pricing reference country list

24 November 2022 - The Government said it would additionally reference Canada and Australia when setting drug prices from January ...

Read more →

MSAC Secretariat publishes agenda for March 2023 MSAC meeting

23 November 2022 - The MSAC Secretariat has published a list of applications scheduled to be considered by the MSAC ...

Read more →

Agenda for the March 2023 PBAC meeting

23 November 2022 - The agenda for the March 2023 PBAC meeting is now available. ...

Read more →

COVID-19 vaccine safety report (17 November 2022)

17 November 2022 - To 13 November 2022, the TGA has received 706 reports which have been assessed as likely to ...

Read more →

Medicines industry calls for discount rate reduction now

18 November 2022 - Medicines Australia welcomes the recommendation to lower the discount rate for medicines and vaccines but questions ...

Read more →

PBAC Public Summary Document (November 2022)

18 November 2022 - The Public Summary Documents for the Review of the base-case discount rate in the PBAC Guidelines from ...

Read more →

Amarin announces Vazkepa (icosapent ethyl) approved by the TGA in Australia

15 November 2022 - Marks fifth regulatory approval for Vascepa/Vazkepa franchise in key international markets in 2022. ...

Read more →

New COVID-19 vaccines for eligible Australians

15 November 2022 - The Australian Government has accepted a recommendation from the Australian Technical Advisory Group on Immunisation (ATAGI) on ...

Read more →

TGA grants provisional determination to Pfizer’s COVID-19 bivalent (Comirnaty Bivalent Omicron BA.4/BA.5) booster dose vaccine

16 November 2022 - On 15 November 2022, the TGA granted a provisional determination to Pfizer’s bivalent COVID-19 vaccine candidate: tozinameran ...

Read more →

ATAGI recommendations on use of the Pfizer COVID-19 vaccine for children aged 6 months to 4 years

15 November 2022 - On 29 September 2022, the TGA provisionally approved Comirnaty (Pfizer) COVID-19 vaccine for use in children ...

Read more →

ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.1) COVID-19 vaccine

15 November 2022 - On 27 October 2022, the TGA provisionally approved the Pfizer (Comirnaty) Bivalent Original/Omicron BA.1 vaccine (subsequently referred ...

Read more →

ATAGI update on boosters following COVID-19 meeting on 11 November 2022

15 November 2022 - An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their meeting on 11 November ...

Read more →

COVID-19 vaccine safety report (3 November 2022)

3 November 2022 - To 30 October 2022, the TGA has received 704 reports which have been assessed as likely to ...

Read more →

Government supporting Australians living with type 1 diabetes

13 November 2022 - The Albanese Government is changing the lives for the 130,000 Australians living with type 1 diabetes by ...

Read more →

NSW pharmacists to prescribe the pill, antibiotics in health shake-up

13 November 2022 - Pharmacists will be able to prescribe a range of meds and repeat scripts under a NSW government ...

Read more →